100 related articles for article (PubMed ID: 17674415)
21. Noradrenergic alterations in Parkinson's disease: a combined 11C-yohimbine PET/neuromelanin MRI study.
Laurencin C; Lancelot S; Brosse S; Mérida I; Redouté J; Greusard E; Lamberet L; Liotier V; Le Bars D; Costes N; Thobois S; Boulinguez P; Ballanger B
Brain; 2024 Apr; 147(4):1377-1388. PubMed ID: 37787503
[TBL] [Abstract][Full Text] [Related]
22. Physical Exercise as a Potential Treatment for Fatigue in Parkinson's Disease? A Systematic Review and Meta-Analysis of Pharmacological and Non-Pharmacological Interventions.
Folkerts AK; Nielsen J; Gollan R; Lansu A; Solfronk D; Monsef I; Ernst M; Skoetz N; Zeuner KE; Kalbe E
J Parkinsons Dis; 2023; 13(5):659-679. PubMed ID: 37334618
[TBL] [Abstract][Full Text] [Related]
23. The Link Between Energy-Related Sensations and Metabolism: Implications for Treating Fatigue.
Filippi M; Krähenmann R; Fissler P
Front Psychol; 2022; 13():920556. PubMed ID: 35800955
[TBL] [Abstract][Full Text] [Related]
24. Multiple sclerosis-related fatigue lacks a unified definition: A narrative review.
Adibi I; Sanayei M; Tabibian F; Ramezani N; Pourmohammadi A; Azimzadeh K
J Res Med Sci; 2022; 27():24. PubMed ID: 35419061
[TBL] [Abstract][Full Text] [Related]
25. Stimulant Induced Movement Disorders in Attention Deficit Hyperactivity Disorder.
Nam SH; Lim MH; Park TW
Soa Chongsonyon Chongsin Uihak; 2022 Apr; 33(2):27-34. PubMed ID: 35418800
[TBL] [Abstract][Full Text] [Related]
26. Impaired dopamine metabolism is linked to fatigability in mice and fatigue in Parkinson's disease patients.
Scheffer DDL; Freitas FC; Aguiar AS; Ward C; Guglielmo LGA; Prediger RD; Cronin SJF; Walz R; Andrews NA; Latini A
Brain Commun; 2021; 3(3):fcab116. PubMed ID: 34423297
[TBL] [Abstract][Full Text] [Related]
27. Frontal Transcranial Direct Current Stimulation as a Potential Treatment of Parkinson's Disease-Related Fatigue.
Zaehle T
Brain Sci; 2021 Apr; 11(4):. PubMed ID: 33917684
[TBL] [Abstract][Full Text] [Related]
28. Clinical Perspectives of Parkinson's Disease for Ophthalmologists, Otorhinolaryngologists, Cardiologists, Dentists, Gastroenterologists, Urologists, Physiatrists, and Psychiatrists.
Choi JH; Kim JM; Yang HK; Lee HJ; Shin CM; Jeong SJ; Kim WS; Han JW; Yoon IY; Song YS; Bae YJ
J Korean Med Sci; 2020 Jul; 35(28):e230. PubMed ID: 32686370
[TBL] [Abstract][Full Text] [Related]
29. Cognitive Fatigability Interventions in Neurological Conditions: A Systematic Review.
Walker LAS; Lindsay-Brown AP; Berard JA
Neurol Ther; 2019 Dec; 8(2):251-271. PubMed ID: 31586303
[TBL] [Abstract][Full Text] [Related]
30. deepDR: a network-based deep learning approach to in silico drug repositioning.
Zeng X; Zhu S; Liu X; Zhou Y; Nussinov R; Cheng F
Bioinformatics; 2019 Dec; 35(24):5191-5198. PubMed ID: 31116390
[TBL] [Abstract][Full Text] [Related]
31. The Neuropsychiatry of Parkinson Disease: A Perfect Storm.
Weintraub D; Mamikonyan E
Am J Geriatr Psychiatry; 2019 Sep; 27(9):998-1018. PubMed ID: 31006550
[TBL] [Abstract][Full Text] [Related]
32. The Pathophysiology of Fatigue in Parkinson's Disease and its Pragmatic Management.
Kostić VS; Tomić A; Ječmenica-Lukić M
Mov Disord Clin Pract; 2016; 3(4):323-330. PubMed ID: 30363584
[TBL] [Abstract][Full Text] [Related]
33. Open-label placebo reduces fatigue in cancer survivors: a randomized trial.
Zhou ES; Hall KT; Michaud AL; Blackmon JE; Partridge AH; Recklitis CJ
Support Care Cancer; 2019 Jun; 27(6):2179-2187. PubMed ID: 30298411
[TBL] [Abstract][Full Text] [Related]
34. Feasibility study of a randomised controlled trial to investigate the treatment of sarcoidosis-associated fatigue with methylphenidate (FaST-MP): a study protocol.
Atkins C; Fordham R; Clark AB; Stockl A; Jones AP; Wilson AM
BMJ Open; 2017 Dec; 7(12):e018532. PubMed ID: 29208618
[TBL] [Abstract][Full Text] [Related]
35. Effort but not Reward Sensitivity is Altered by Acute Sickness Induced by Experimental Endotoxemia in Humans.
Draper A; Koch RM; van der Meer JW; Aj Apps M; Pickkers P; Husain M; van der Schaaf ME
Neuropsychopharmacology; 2018 Apr; 43(5):1107-1118. PubMed ID: 28948979
[TBL] [Abstract][Full Text] [Related]
36. Cognitive fatigue in individuals with traumatic brain injury is associated with caudate activation.
Wylie GR; Dobryakova E; DeLuca J; Chiaravalloti N; Essad K; Genova H
Sci Rep; 2017 Aug; 7(1):8973. PubMed ID: 28827779
[TBL] [Abstract][Full Text] [Related]
37. Methylphenidate, cognition, and epilepsy: A double-blind, placebo-controlled, single-dose study.
Adams J; Alipio-Jocson V; Inoyama K; Bartlett V; Sandhu S; Oso J; Barry JJ; Loring DW; Meador K
Neurology; 2017 Jan; 88(5):470-476. PubMed ID: 28031390
[TBL] [Abstract][Full Text] [Related]
38. Fatigue in Parkinson's disease: The contribution of cerebral metabolic changes.
Cho SS; Aminian K; Li C; Lang AE; Houle S; Strafella AP
Hum Brain Mapp; 2017 Jan; 38(1):283-292. PubMed ID: 27571419
[TBL] [Abstract][Full Text] [Related]
39. Managing fatigue in sarcoidosis - A systematic review of the evidence.
Atkins C; Wilson AM
Chron Respir Dis; 2017 May; 14(2):161-173. PubMed ID: 27507833
[TBL] [Abstract][Full Text] [Related]
40. The recommendations of Chinese Parkinson's disease and movement disorder society consensus on therapeutic management of Parkinson's disease.
Chen S; Chan P; Sun S; Chen H; Zhang B; Le W; Liu C; Peng G; Tang B; Wang L; Cheng Y; Shao M; Liu Z; Wang Z; Chen X; Wang M; Wan X; Shang H; Liu Y; Xu P; Wang J; Feng T; Chen X; Hu X; Xie A; Xiao Q
Transl Neurodegener; 2016; 5():12. PubMed ID: 27366321
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
